Catherine Skari
-
Dec- 2024 -19 DecemberNews
TIF READINESS ASSESSMENT TOOL | Is Your Country Ready for Advanced Thalassaemia Therapies?
In an era where medical advancements are progressing at an unprecedented rate, ensuring that these breakthroughs are accessible and appropriately…
Read More » -
18 DecemberNews
WEBINAR | New Advances in the Prevention of Thalassaemia: Potential for High-Prevalence Regions
📌 Webinar Title: New Advances in the Prevention of Thalassaemia: Potential for High-Prevalence Regions 📌 Date & Time: Tuesday, 21 January…
Read More » -
11 DecemberNews
NEW FACTSHEET | The Advanced Therapy Medicinal Products (ATMPs) Labyrinth
Featuring comprehensive information on: The Regulation of ATMPs in the EU List of gene-based products approved by the EMA/FDA Challenges…
Read More » -
Nov- 2024 -20 NovemberNews
POSITION PAPER | The Views of TIF on Advanced Therapy Medicinal Products (ATMPs)
The Thalassaemia International Federation (TIF) is pleased to share its newly published Position Paper, titled “Advanced Therapy Medicinal Products (ATMPs).”…
Read More » -
19 NovemberNews
INFOGRAPHICS | Mapping Blood Use in Patients with Thalassaemia Across the EU
Have You Ever Wondered How Much Blood is Consumed by Patients with Thalassaemia in EU Countries? To answer this question,…
Read More » -
14 NovemberNews
EXCLUSIVE WEBINAR | Iron Load and the Importance of Reliable Monitoring in Haemoglobin Disorders
📌 Webinar Title: Iron Load and the Importance of Reliable Monitoring in Haemoglobin Disorders – The Transfusion Dependent Thalassaemia (TDT)…
Read More » -
4 NovemberNews
EDUCATIONAL WEBINAR FOR PATIENTS ON IRON OVERLOAD AND MONITORING | 21 November 2024
📌 Webinar Title: Webinar for Patients on Iron Overload and Iron Monitoring 📌 Date & Time: Thursday, November 21, 13:00…
Read More » -
Oct- 2024 -29 OctoberNews
SICKLE CELL DISEASE | FDA Grants Orphan Drug Designation to AND017
Announced by KIND Pharmaceuticals on October 25, 2024, ODD is granted to a drug or biological product to prevent, diagnose,…
Read More » -
17 OctoberSurveys
TIF STUDY | Desferioxamine Usage Survey
Desferioxamine is crucial in managing iron overload for many patients with thalassaemia and related blood conditions. Recently, the Thalassaemia International…
Read More » -
17 October

